Cardiovascular

Acute coronary syndrome: mechanical complications after MI

Clinical Overview and When to Suspect Mechanical Complications After MI

— Incidence <1% with timely PCI but mortality remains 20–75% depending on lesion

— Median onset 2–7 days post-MI; bimodal (within 24h or 3–5 days as macrophage-mediated necrosis peaks)

— Late presentations (1–2 weeks) increasingly seen with delayed/no reperfusion

— First MI (no collaterals), anterior STEMI, advanced age, female sex, hypertension, late presentation (>12h), no reperfusion, single-vessel disease, thin infarct zone

— Inferior/inferoposterior MI → posteromedial papillary muscle rupture (single blood supply from PDA)

— Anterior LAD MI → apical VSR or apical FWR

— Inferior MI → basal/inferior VSR (worse prognosis, complex anatomy)

— Sudden hypotension + pulmonary edema → think PMR

— New harsh holosystolic murmur + biventricular failure + step-up in O₂ saturation → VSR

— PEA arrest with JVD and muffled heart sounds → FWR with tamponade

— Persistent ST elevation + new murmur weeks later → pseudoaneurysm or true aneurysm

Board pearl: Any post-MI patient with abrupt hemodynamic decompensation between days 2 and 7 needs a bedside transthoracic echo within minutes, not hours — this is the single highest-yield test and is the Step 3 reflexive next step before labs return.

Definition: Structural cardiac failures arising from necrotic, weakened myocardium after acute MI — papillary muscle rupture (PMR), ventricular septal rupture (VSR), free wall rupture (FWR), LV pseudoaneurysm, true aneurysm, and dynamic LVOT obstruction.

Epidemiology in the reperfusion era:

High-risk substrate:

When to suspect on Step 3 stem: Day 2–7 post-MI patient develops new hemodynamic deterioration:

Why it matters: Mechanical complications change the entire trajectory — these patients need urgent echo, mechanical circulatory support (MCS), and surgical or transcatheter repair, not just titration of GDMT.

Presentation Patterns and Key History

— 0–24h: early FWR (rare, transmural anterior MI, no reperfusion)

— 2–7 days: peak window for PMR, VSR, FWR (macrophage infiltration thins wall)

— >2 weeks: LV aneurysm, pseudoaneurysm, Dressler syndrome

— Abrupt flash pulmonary edema, often without preceding gradual decline

— Dyspnea at rest, pink frothy sputum, cardiogenic shock

— Inferior/posterior MI history is classic (posteromedial PM has single PDA supply)

— Sudden chest pain recurrence + new murmur + biventricular failure

— RV failure signs (JVD, hepatic congestion) often dominate when shunt is large

— Anterior MI → apical VSR (simpler); inferior MI → basal VSR (complex, serpiginous)

— Sudden chest pain, syncope, then PEA or asystole

— Subacute form: nausea, vomiting, hypotension, transient bradycardia (vagal from pericardial blood)

— Often heralded by recurrent pericarditic pain post-MI

— Contained rupture by pericardium/thrombus

— Insidious dyspnea, palpitations, sometimes thromboembolic stroke

— Can present weeks to months later

— Apical anterior MI with hyperdynamic basal segments → SAM-like physiology

— Worsened by inotropes, diuresis, vasodilators

— Time from symptom onset to reperfusion (delayed = high risk)

— Whether thrombolytics or PCI were performed

— NSAID/glucocorticoid use post-MI (impairs healing → rupture risk)

— Recurrent pleuritic chest pain (impending rupture marker)

Step 3 management: When you see "day 4 post-inferior MI, sudden dyspnea, new murmur" — the stem is steering you to mechanical complication; order stat TTE, place arterial line, hold further negative inotropes, and call CT surgery before chasing troponin trends.

Timing pearls (memorize the clock):

Papillary muscle rupture (PMR):

Ventricular septal rupture (VSR):

Free wall rupture (FWR):

Pseudoaneurysm:

Dynamic LVOT obstruction:

History red flags to elicit:

Physical Exam Findings and Hemodynamic Assessment

— New apical holosystolic or early systolic murmur, often soft or absent due to rapid LA pressure equalization (large flail leaflet, low gradient)

— S3 gallop, bibasilar crackles, cool extremities, narrow pulse pressure

— Murmur does not radiate to axilla reliably in acute severe MR (unlike chronic)

— Harsh, loud holosystolic murmur at left lower sternal border, often with palpable thrill (~50%)

— Biventricular failure: elevated JVP, hepatomegaly, ascites + pulmonary edema

— Hypotension, mottling

— Beck's triad: hypotension, JVD, muffled heart sounds

— Pulsus paradoxus, PEA, electromechanical dissociation

— Pericardial friction rub may precede rupture

— To-and-fro murmur (systolic and diastolic), variable

— May be asymptomatic until embolic event

— PMR: giant V waves in PCWP tracing, elevated PCWP, low CO, normal RA

— VSR: oxygen step-up ≥7% from RA to RV/PA (pathognomonic), elevated RA and PCWP, low systemic CO

— FWR/tamponade: equalization of diastolic pressures (RA = RVEDP = PCWP), prominent x descent, blunted y

— RV infarction mimic: elevated RA disproportionate to PCWP, but no step-up and no new murmur

— Flail leaflet on TTE, color Doppler regurgitant jet (PMR)

— Septal defect with left-to-right shunt (VSR)

— Pericardial effusion with RV diastolic collapse (FWR)

Key distinction: Acute severe MR from PMR often produces a soft or even silent murmur because the LA is non-compliant — never use murmur intensity to rule it out; trust the echo and the clinical picture of flash pulmonary edema in a post-MI patient.

Papillary muscle rupture:

Ventricular septal rupture:

Free wall rupture:

Pseudoaneurysm:

Hemodynamics — Swan-Ganz / invasive findings:

Bedside ultrasound clues:

Diagnostic Workup — Initial Labs, ECG, and Biomarkers

— PMR: often nondiagnostic; inferior MI pattern (II, III, aVF) with reciprocal changes; new atrial fibrillation from LA stretch

— VSR: AV block in inferior VSR (40%), persistent ST elevation, RBBB common

— FWR: transient bradycardia, junctional rhythm, then PEA; persistent ST elevation

— LV aneurysm: persistent ST elevation >2 weeks post-MI in leads with Q waves (classic anterior precordial)

— Pseudoaneurysm: persistent ST elevation, nonspecific

— Troponin may already be falling from index MI; secondary rise suggests extension or rupture

— BNP/NT-proBNP markedly elevated (acute volume overload)

— Lactate elevated in cardiogenic shock (prognostic marker, follow trend)

— Mixed venous O₂ saturation low (<60%) in shock; elevated in left-to-right shunt of VSR

— Anemia worsens shock — transfuse to Hgb >8 (>10 if active ischemia)

— Cr rise heralds cardiorenal syndrome

— INR and platelets needed pre-op

— Pulmonary edema (often unilateral right-sided in eccentric MR jet directed at RUL pulmonary vein)

— Enlarged cardiac silhouette suggests pericardial effusion

— Hypoxemia, mixed respiratory/metabolic acidosis in shock

— Document use of NSAIDs, steroids, anticoagulants

— Coags before considering surgical or percutaneous repair

CCS pearl: In a CCS case of post-MI hemodynamic collapse, the immediate orders are: stat 12-lead ECG, stat portable CXR, stat bedside echo, type & cross 4 units, arterial line, central line, ABG, lactate, troponin, BNP, CBC, BMP, INR/PTT, and cardiothoracic surgery consult — all concurrently, not sequentially.

ECG findings by complication:

Biomarkers:

CBC, BMP, coags:

CXR:

ABG:

Lactate, ScvO₂: Serial measurements guide MCS escalation

Hold/check medications:

Diagnostic Workup — Advanced and Confirmatory Studies

— Identifies severe MR with flail leaflet (PMR), septal defect with shunt (VSR), pericardial effusion (FWR), aneurysm/pseudoaneurysm contour

— Color Doppler quantifies regurgitation and shunt fraction (Qp/Qs)

— Estimates RVSP, LV function, regional wall motion

— When TTE windows are poor (intubated, obese, post-op)

— Superior for identifying which papillary muscle is involved and characterizing VSR morphology for surgical planning

— Gold standard for distinguishing true vs pseudoaneurysm:

– True aneurysm: wide neck, full wall layers, low rupture risk

– Pseudoaneurysm: narrow neck (neck:body ratio <0.5), no myocardium in wall, high rupture risk → urgent repair

— Reserved for stable patients with diagnostic ambiguity

— Best characterization of pseudoaneurysm, thrombus, scar burden

— Not for unstable patients

— Rapid in ED for ruling out aortic dissection or PE differentials

— Can identify pseudoaneurysm and pericardial hematoma

— Confirms VSR with O₂ step-up RA→RV ≥7%

— Quantifies Qp/Qs (>2:1 = large shunt)

— Guides vasopressor/inotrope/MCS titration in shock

— Performed before surgical repair to define bypass targets

— Avoid delay if patient is in extremis — operate on clinical/echo data

— Diagnostic and temporizing for tamponade from subacute FWR

— Bloody, non-clotting aspirate confirms hemopericardium

Board pearl: A narrow neck on echo is the single best discriminator between pseudoaneurysm (surgery) and true aneurysm (medical management) — pseudoaneurysm contains only pericardium and thrombus and ruptures freely.

Transthoracic echo (TTE) — first-line:

Transesophageal echo (TEE):

Cardiac MRI:

CT angiography:

Right heart catheterization (PA catheter):

Left heart catheterization / coronary angiography:

Pericardiocentesis:

Risk Stratification and First-Line Management Logic

— Stable, no shock → medical optimization, urgent (not emergent) surgical planning

— Cardiogenic shock (SCAI stage C–E) → MCS bridge to surgery

— Cardiac arrest/PEA from FWR → emergent pericardiocentesis + OR

— A (at risk) → B (beginning) → C (classic shock) → D (deteriorating) → E (extremis)

— Mechanical complications usually present at C or worse; goal is preventing D/E

— PMR: ~75% at 24h without surgery

— VSR: ~25% at 24h, ~90% at 2 months medical only

— FWR: >90% acute mortality unless subacute and surgically rescued

— Pseudoaneurysm: ~30–45% rupture risk → repair regardless of symptoms

— True aneurysm: managed medically unless refractory HF, arrhythmia, or thrombus

— PMR: early surgery (within hours) is standard — mortality high but only option

— VSR: historically delayed to allow tissue to "firm up," but contemporary data favor early repair in shock; stable patients may benefit from short delay (7–14 days) with MCS

— FWR: emergent surgery; pericardiocentesis temporizes

— Reduce afterload (IABP, vasodilators if BP allows) to decrease regurgitant/shunt fraction

— Avoid pure vasoconstrictors (worsen MR/VSR)

— Diuresis cautiously

— Mechanical ventilation with PEEP for pulmonary edema

— Interventional cardiology, CT surgery, cardiac anesthesia, critical care, palliative care

— Shared decision-making especially for elderly/frail

Step 3 management: First move in confirmed mechanical complication with shock = IABP placement + inotrope (dobutamine or milrinone) + vasodilator if BP tolerates + emergent surgical consult. Do not delay for diuresis or full workup.

Stratify by hemodynamics and mechanical lesion:

SCAI shock staging applied:

Mortality by complication (unrepaired):

Timing of surgery — the controversial axis:

Initial stabilization priorities:

Multidisciplinary heart team:

Pharmacotherapy — First-Line Drug Regimen

— Sodium nitroprusside 0.3–10 mcg/kg/min if SBP >90 — reduces regurgitant fraction and L→R shunt

— Nitroglycerin 10–200 mcg/min — preferred if ongoing ischemia

— Both titrated to MAP 65 mmHg and clinical response

— Contraindicated if SBP <90 without MCS support

— Dobutamine 2.5–10 mcg/kg/min — β₁ agonist, augments CO, mild vasodilation; risk of arrhythmia and ischemia

— Milrinone 0.125–0.5 mcg/kg/min — PDE3 inhibitor, inodilator; better in RV failure; renally cleared (caution in AKI)

— Avoid in hypotensive patients without concurrent vasopressor

— Norepinephrine preferred first-line in cardiogenic shock (lower arrhythmia than dopamine)

— Vasopressin as second agent, sparing catecholamines

— Avoid phenylephrine alone (raises afterload without inotropy)

— IV furosemide bolus or infusion for pulmonary edema, titrate to UOP >0.5 mL/kg/h

— Avoid aggressive preload reduction in RV infarct/tamponade physiology

— Continue aspirin

— Hold P2Y12 inhibitor 5–7 days pre-CABG/surgical repair (ticagrelor 3–5d, clopidogrel 5d, prasugrel 7d)

— Heparin infusion until OR; bridge from DOAC if applicable

— Pure β-blockers in acute shock

— NSAIDs and glucocorticoids (impair healing, ↑rupture risk in first 2 weeks)

— ACE inhibitors in active hypotension

Board pearl: Nitroprusside + IABP + dobutamine is the classic triad for stabilizing acute MR or VSR pre-op; nitroprusside drops afterload, IABP augments diastolic perfusion and reduces afterload, dobutamine drives forward flow.

Afterload reduction (cornerstone for PMR and VSR):

Inotropes:

Vasopressors (when MAP <65 despite MCS):

Diuretics:

Antiplatelets/anticoagulation:

Avoid:

Procedures — MCS, Surgical Repair, and Transcatheter Options

— IABP: first-line, easy, reduces afterload, augments coronary perfusion; modest CO support (~0.5 L/min); contraindicated in severe AI, aortic dissection

— Impella CP/5.5: axial flow pump, 3.5–5 L/min support; preferred in severe LV failure without large VSR (VSR can worsen R→L flow through Impella)

— VA-ECMO: for biventricular failure, refractory shock, cardiac arrest; risk of LV distension → often paired with Impella ("ECPELLA") or IABP for venting

— TandemHeart: transseptal LA-to-femoral artery; complex setup

— PMR: mitral valve replacement (usually) or repair; concurrent CABG if needed

— VSR: patch closure (Daggett or infarct exclusion technique); apical lesions easier; basal/inferior lesions higher mortality

— FWR: sutureless patch with bioglue, or direct repair if subacute and contained

— Pseudoaneurysm: resection and patch

— True aneurysm: aneurysmectomy if refractory HF, VT, or mural thrombus despite anticoagulation

— Percutaneous VSR closure (Amplatzer occluder) — for residual or recurrent post-surgical VSR, or high-risk surgical candidates

— Transcatheter edge-to-edge repair (MitraClip) for PMR — emerging option in non-surgical candidates

— Residual shunt is common; high in-hospital mortality (~30%)

— For subacute FWR with tamponade — temporizing only, do not drain dry (re-bleed risk)

— Bridge to OR within hours

CCS pearl: When advancing the clock in CCS shock cases, do not "watch and wait" on mechanical complications — every hour of delay adds mortality. Order IABP, type & cross, OR booking, and NPO status in parallel; the simulator rewards aggressive concurrent action.

Mechanical circulatory support (MCS) — bridge to surgery:

Surgical repair — definitive:

Transcatheter options:

Pericardiocentesis:

Special Populations — Elderly and Renal/Hepatic Impairment

— Higher baseline incidence of mechanical complications (atrophic, fibrotic myocardium ruptures more easily)

— Operative mortality 40–60% for VSR repair, 25–40% for PMR repair

— Frailty assessment (gait speed, grip strength, Clinical Frailty Scale) should inform candidacy

— Shared decision-making essential; transcatheter approaches and palliative pathways often preferable

— Postoperative delirium prevention: minimize benzodiazepines, early mobilization, sleep hygiene, family presence

— Contrast nephropathy risk during cath — minimize contrast, hydrate, hold metformin/SGLT2

— Milrinone renally cleared — reduce dose if CrCl <50; consider dobutamine instead

— Nitroprusside → thiocyanate/cyanide toxicity in renal failure, especially infusions >48h or >3 mcg/kg/min; monitor for metabolic acidosis, AMS; use nitroglycerin instead

— Diuretic resistance common — combine loop + thiazide (metolazone) or CRRT for volume removal

— Post-op AKI is a major mortality driver

— Congestive hepatopathy from RV failure (VSR) → coagulopathy, thrombocytopenia

— Adjust sedation (avoid prolonged midazolam, prefer dexmedetomidine)

— Vitamin K and FFP if INR elevated pre-op

— Required for IABP, Impella, ECMO; bleeding risk higher in elderly/CKD

— Monitor anti-Xa or aPTT closely; HIT screen if platelets drop

— For octogenarians in SCAI stage E with multiorgan failure, palliative pathway is appropriate and ethical

— Document code status, surrogate decision-maker, advance directives early

Step 3 management: In an 82-year-old with VSR and CKD stage 4 in shock, engage palliative care alongside surgery consult on day 1 — Step 3 expects parallel goals-of-care conversations, not sequential ones.

Elderly (>75 years):

Chronic kidney disease / AKI:

Hepatic impairment:

Anticoagulation balance:

Goals-of-care discussion:

Special Populations — Pregnancy, Younger Patients, and Other Subgroups

— MI in pregnancy is rare but rising; SCAD (spontaneous coronary artery dissection) is the leading cause peripartum

— Mechanical complications managed with multidisciplinary team (cardiology, MFM, CT surgery, anesthesia)

— Avoid teratogens: ACEi, ARB, warfarin (1st trimester), statins, amiodarone

— Heparin preferred over DOACs; aspirin acceptable

— Delivery planning: vaginal delivery with epidural and shortened second stage usually safer than C-section in stable patients

— Consider cocaine/amphetamine-induced MI, SCAD, vasculitis, hypercoagulable states

— Higher likelihood of single-vessel disease and large transmural infarcts → higher mechanical complication risk

— Aggressive revascularization and full GDMT post-discharge

— Atypical/silent MI presentations delay diagnosis → larger infarcts, more rupture

— Tighter glycemic control in ICU (140–180 mg/dL); avoid hypoglycemia

— SGLT2 inhibitors post-discharge (dapagliflozin, empagliflozin) reduce HF readmission

— Higher risk of hemorrhagic complications including hemopericardium from FWR

— Anticoagulation reversal may be needed pre-op (cryoprecipitate, FFP, TXA for tPA)

— Surgical re-entry higher risk; consider transcatheter approaches

— Women have higher rates of FWR and VSR, present later, smaller body habitus, and higher operative mortality

— Recognize atypical presentations (nausea, fatigue, jaw pain)

Board pearl: Peripartum patient with chest pain → think SCAD first, manage conservatively when possible (PCI carries propagation risk); mechanical complications managed identically but with fetal monitoring and team coordination.

Pregnancy and peripartum:

Young patients (<45):

Diabetes mellitus:

Post-fibrinolytic patients:

Patients with prior CABG:

Sex differences:

Complications and Adverse Outcomes

— Cardiogenic shock progression despite MCS (mortality 40–60%)

— Multiorgan failure: AKI, hepatic congestion, ischemic bowel, ARDS

— Recurrent ischemia or extension of MI

— Ventricular arrhythmias: VT/VF from scar substrate; manage with amiodarone, lidocaine, defibrillation, consider wearable defibrillator at discharge

— Atrial fibrillation from LA stretch (PMR) — rate/rhythm control + anticoagulation

— Stroke: embolic from LV thrombus, aortic atheroma during cannulation, or hypoperfusion

— IABP: limb ischemia, balloon rupture, thrombocytopenia, infection

— Impella: hemolysis (free hemoglobin, dark urine, ↑LDH), aortic valve injury, device migration

— ECMO: bleeding, HIT, oxygenator failure, Harlequin syndrome (differential hypoxia in VA-ECMO)

— Residual VSR (10–25%) — may need percutaneous closure or redo surgery

— Prosthetic valve dysfunction or paravalvular leak (post-MVR for PMR)

— Low cardiac output syndrome post-bypass

— Sternal wound infection, mediastinitis (especially in diabetes)

— Atrial fibrillation post-op (40%)

— Heart failure (HFrEF) with need for advanced therapies (LVAD, transplant)

— Recurrent VT from scar → ICD evaluation at 40 days post-MI (or 90 days post-revascularization) if LVEF ≤35%

— Depression and PTSD post-ICU — screen with PHQ-9

— Pericarditis (Dressler syndrome) 2–10 weeks post-MI

— Shock at presentation, age, basal/inferior VSR location, renal failure, time-to-surgery, lactate >4

Key distinction: Hemolysis on Impella (rising LDH, dark urine, falling Hgb without bleeding) is a device positioning/suction problem — adjust depth under TTE guidance before assuming pump failure.

Early in-hospital complications:

MCS-related complications:

Surgical complications:

Late complications:

Mortality predictors:

When to Escalate — ICU, Consults, and Triage

— Any confirmed mechanical complication, regardless of hemodynamics

— SCAI stage B or worse (any hypotension, lactate elevation, end-organ hypoperfusion)

— New murmur post-MI pending echo

— Cardiac arrest survivor with post-MI substrate

— Cardiothoracic surgery (definitive repair)

— Interventional cardiology (cath, percutaneous VSR closure, MCS)

— Cardiac anesthesia (intraop and MCS management)

— Heart failure / advanced therapies (transplant/LVAD evaluation if not a surgical candidate)

— Palliative care for goals-of-care alignment

— Nephrology if AKI or CRRT anticipated

— Community hospital → tertiary center with CT surgery and MCS capability for any mechanical complication

— Use ground or air transport with continuous monitoring, established arterial line, ongoing MCS if initiated

— EMTALA-compliant transfer: accepting physician name documented, vitals stable enough for transport, all imaging/records sent

— Change location: ED → CICU within first time advance

— Activate cath lab AND OR concurrently

— NPO, foley, NG tube, arterial line, central line, intubation if respiratory failure

— Continuous telemetry, pulse oximetry, arterial BP, end-tidal CO₂

— Early, frequent, structured updates — set expectations on mortality (30–60%)

— Identify surrogate, confirm code status, discuss MCS and surgical risks before initiating

— New murmur, hypotension, JVD, sudden dyspnea, oliguria, AMS

CCS pearl: In CCS, ordering "transfer to CICU" plus "cardiothoracic surgery consult, stat" within the first clock advance after suspecting a mechanical complication is heavily rewarded — delaying these for additional imaging loses points.

Immediate CICU/CTICU admission criteria:

Consults — call all simultaneously:

Transfer criteria:

CCS triage moves:

Family communication:

Rapid response triggers post-MI on the floor:

Key Differentials — Same-Category Post-MI Causes

— Recurrent chest pain, new ST changes, troponin re-elevation

— No new murmur; echo shows new wall motion abnormality, not regurgitation or shunt

— Management: emergent repeat angiography

— Inferior MI with hypotension, clear lungs, elevated JVP — mimics tamponade

— ECG: ST elevation in V4R (right-sided leads)

— Echo: RV dilation, hypokinesis; no pericardial effusion, no VSR

— Management: fluid loading, avoid nitrates and diuretics, inotropic support

— Large anterior MI with LVEF <30%, no mechanical lesion on echo

— No new murmur, no step-up, no effusion

— Management: revascularization, MCS, inotropes

— 2–10 weeks post-MI, pleuritic chest pain, friction rub, low-grade fever

— Diffuse ST elevation, PR depression on ECG

— Effusion usually small, non-tamponading

— Management: high-dose aspirin (preferred post-MI) + colchicine; avoid NSAIDs and steroids in first 4 weeks (impair healing)

— Days 1–4, localized to infarct region, transient

— Aspirin only; no colchicine needed

— Anterior apical MI, akinetic/dyskinetic segment

— Risk of embolic stroke, peripheral embolism

— Anticoagulate with warfarin (INR 2–3) or DOAC for 3–6 months

— Persistent ST elevation >2 weeks, dyskinetic apical segment

— Manage HF, anticoagulate if thrombus, surgery only for refractory symptoms

Key distinction: VSR vs acute MR — both cause new murmur and shock days post-MI. The discriminator is the O₂ step-up on right heart cath (VSR only) and murmur location (LLSB with thrill = VSR; apical without thrill = MR). Echo settles it.

Recurrent ischemia / stent thrombosis:

RV infarction:

Cardiogenic shock from pump failure alone:

Dressler syndrome (post-MI pericarditis):

Early infarct-related pericarditis:

LV mural thrombus:

True LV aneurysm:

Key Differentials — Other-Category Causes of Post-MI Decompensation

— Immobilized post-MI patient, sudden dyspnea, hypoxia, RV strain on echo

— D-dimer elevated (nonspecific post-MI), CTPA confirms

— Management: anticoagulation; thrombolysis if massive — but balance bleeding risk after recent MI

— Tearing chest/back pain, pulse deficit, widened mediastinum, new AI murmur

— Can mimic or coexist with MI (proximal dissection occludes RCA → inferior MI)

— CT angio or TEE; emergent surgery; do not anticoagulate

— Post-central-line, post-CPR, mechanically ventilated patient

— Absent breath sounds, tracheal deviation, hyperresonance

— Needle decompression then chest tube

— Hospital-acquired pneumonia, CLABSI, UTI from foley

— Warm extremities (early), elevated WBC, fevers, lactate elevation

— Source control, broad-spectrum antibiotics, fluids

— Hypotension, tachycardia, melena, drop in Hgb

— Hold anticoagulation, transfuse, EGD; balance against stent thrombosis risk

— Post-cath patient with rising Cr, oliguria, pulmonary edema

— Distinct from mechanical complication — no new murmur, normal echo

— Over-diuresis, β-blocker excess, ACEi after volume-deplete state

— Hold offending agent, fluid challenge cautiously

— Apical ballooning in emotionally stressed post-MI patient

— Usually reversible; supportive care

Board pearl: Always re-examine and re-image when a post-MI patient deteriorates — the second hit may not be cardiac. PE and GI bleed are commonly missed in patients labeled as "MI shock."

Pulmonary embolism:

Aortic dissection (type A):

Tension pneumothorax:

Sepsis / septic shock:

GI bleed from antiplatelet/anticoagulant:

Contrast nephropathy with volume overload:

Medication-induced hypotension:

Stress (Takotsubo) cardiomyopathy:

Secondary Prevention and Discharge Medications

— Dual antiplatelet therapy (DAPT): aspirin 81 mg indefinitely + P2Y12 inhibitor (ticagrelor or prasugrel preferred over clopidogrel post-PCI) for at least 12 months; longer if low bleeding risk

— High-intensity statin: atorvastatin 80 mg or rosuvastatin 40 mg; LDL goal <55 mg/dL (or >50% reduction); add ezetimibe ± PCSK9 inhibitor if not at goal

— β-blocker: metoprolol succinate or carvedilol; continue indefinitely if HFrEF, ≥3 years if EF preserved

— ACEi/ARB: lisinopril, ramipril; especially if LVEF <40%, HTN, DM, CKD

— MRA (spironolactone/eplerenone): if LVEF ≤40% with HF symptoms or DM, and K <5.0, eGFR >30

— SGLT2 inhibitor: dapagliflozin or empagliflozin — now indicated in HFrEF and post-MI with HF regardless of diabetes

— ARNI (sacubitril/valsartan): replaces ACEi in HFrEF once stable; PARADISE-MI showed numerical benefit

— Anticoagulation if mechanical valve (warfarin, INR 2.5–3.5), LV thrombus (3–6 months), or AF (DOAC)

— Endocarditis prophylaxis post-valve replacement before high-risk dental work

— Reassess LVEF at 40 days post-MI (or 90 days post-revascularization); if ≤35% with NYHA II–III despite GDMT, ICD for primary prevention

— Wearable cardioverter-defibrillator (LifeVest) as bridge

— BP <130/80, A1c <7% (relaxed in elderly), tobacco cessation (varenicline, NRT, counseling)

— Influenza, pneumococcal, COVID, RSV vaccines

Step 3 management: A common Step 3 distractor is implanting an ICD too early — wait 40 days post-MI (or 90 days post-revascularization) before reassessing LVEF; many recover function on GDMT and avoid the device.

Guideline-directed medical therapy (GDMT) — start before discharge:

Post–mechanical complication-specific therapy:

ICD evaluation:

Risk factor control:

Mediterranean diet, supervised cardiac rehab referral

Follow-Up, Monitoring, and Rehab/Counseling

— Medication reconciliation with pharmacist

— Teach-back education on each drug, red-flag symptoms

— Smoking cessation pharmacotherapy initiated in hospital

— Cardiac rehab referral before discharge (Class I, improves mortality 20–30%)

— Follow-up appointments scheduled before patient leaves

— PCP visit within 7 days (transitions-of-care visit, CMS quality metric)

— Cardiology within 2 weeks

— Cardiac surgery follow-up at 2 and 6 weeks post-op

— Repeat TTE at 1, 3, and 6 months to assess LVEF recovery, residual shunt, valve function

— Lipid panel at 4–12 weeks after statin initiation; A1c quarterly if diabetic

— BMP within 1–2 weeks of starting/uptitrating ACEi/ARB/MRA (K, Cr)

— 36 supervised sessions over 12 weeks, covered by Medicare post-MI/CABG

— Improves exercise capacity, depression, mortality, readmissions

— Light activity immediately, sexual activity after 1–2 weeks if asymptomatic on moderate exertion

— Driving: 1 week post-MI without complications, longer if shock/arrhythmia; commercial driving requires DOT clearance

— Air travel: usually 2 weeks post-uncomplicated MI, longer with mechanical complication

— Return to work: depends on job demands and recovery

— Screen for depression (PHQ-9), anxiety, PTSD at 2-week and 3-month visits

— Treat with SSRI (sertraline preferred — cardiac safety data)

— Support groups, family counseling

— INR weekly until stable then monthly (warfarin)

— Annual renal function and Hgb on DOAC

Board pearl: The 7-day post-discharge follow-up visit is a Step 3 favorite — it reduces 30-day readmissions and is a CMS-tracked quality measure for MI and HF bundles.

Discharge planning checklist:

Follow-up cadence:

Cardiac rehabilitation:

Activity counseling:

Psychosocial:

Anticoagulation monitoring:

Ethical, Legal, and Patient Safety Considerations

— Mechanical complication patients are often in shock, hypoxic, or sedated — capacity is impaired

— Obtain consent from surrogate decision-maker per state hierarchy (spouse, adult child, parent, sibling)

— If no surrogate and life-threatening: two-physician emergency consent doctrine permits proceeding

— Document conversation, mortality estimate, alternatives (including comfort care), and surrogate's understanding

— For octogenarians in SCAI E with multiorgan failure, surgery may be inappropriate

— Use shared decision-making framework; involve palliative care early

— Honor advance directives, MOLST/POLST forms — failure to do so is both ethical breach and legal liability

— Ethically equivalent to withdrawal of any life-sustaining therapy

— Requires clear documentation, ethics consult if family disagreement, time-limited trial framework

— Medication errors at discharge are the #1 cause of post-MI readmission — reconcile every drug, especially anticoagulants and antiplatelets

— Handoff communication to PCP via written summary within 48h (Joint Commission standard)

— Pillbox, family education, pharmacy delivery for high-risk patients

— Mechanical complications missed when subtle — promote culture of speaking up for nurses noticing new murmurs, hypotension

— Rapid response team activation criteria should include new murmur post-MI

— Drug-induced MI (cocaine) — no reporting required, but document and counsel

— Driver fitness — physician judgment; some states (e.g., California) require reporting impaired drivers

— If a delay in diagnosis contributed to mortality, transparent disclosure to family is both ethical duty and reduces litigation risk (CANDOR programs)

— In shock with mechanical complication, exception from informed consent (EFIC) may apply for resuscitation trials — IRB-approved protocols only

Step 3 management: When a post-MI patient lacks capacity and needs emergent VSR repair, identify the surrogate immediately, document the conversation, and do not delay life-saving surgery if no surrogate is reachable — the two-physician emergency exception applies.

Informed consent for emergency surgery:

Goals-of-care and futility:

Withdrawal of MCS:

Transitions-of-care safety:

Patient safety culture:

Mandatory reporting:

Disclosure of adverse events:

Research/clinical trial enrollment:

High-Yield Associations and Rapid-Fire Facts

Board pearl: If a stem mentions "3–5 days post-MI" plus any sudden change in exam or hemodynamics, the answer is a mechanical complication — pick the echo finding that matches the murmur and physiology.

Posteromedial papillary muscle ruptures more than anterolateral — single blood supply (PDA only) vs dual (LAD + LCx)

Inferior MI → posteromedial PMR or basal VSR; anterior MI → apical VSR, apical FWR, true aneurysm

O₂ step-up RA→RV ≥7% is diagnostic of VSR

Giant V waves on PCWP tracing = severe acute MR (PMR until proven otherwise)

Persistent ST elevation >2 weeks = LV aneurysm

Pseudoaneurysm neck:body ratio <0.5, narrow neck, urgent repair

Beck's triad (hypotension, JVD, muffled heart sounds) = tamponade — think FWR in post-MI patient

Bloody non-clotting pericardial fluid = hemopericardium from FWR

NSAIDs and steroids in first 2 weeks post-MI → impair healing, ↑rupture risk — avoid

Aspirin (not NSAIDs) for post-MI pericarditis; colchicine added in Dressler

Mortality unrepaired: PMR ~75% at 24h, VSR ~25% at 24h and 90% at 2 months, FWR ~90% acute

IABP + dobutamine + nitroprusside = classic stabilization triad

Impella hemolysis = dark urine, ↑LDH, falling Hgb without bleeding — reposition

Reassess LVEF at 40 days post-MI for primary-prevention ICD

Wearable cardioverter-defibrillator (LifeVest) bridges patients with low EF in the 40-day waiting period

SCAD is the leading cause of MI in pregnant women

Cardiac rehab reduces all-cause mortality 20–30% — refer everyone post-MI

Sacubitril/valsartan (ARNI) preferred over ACEi in HFrEF once stable post-MI

SGLT2 inhibitors indicated post-MI with HF regardless of diabetes status

7-day post-discharge follow-up reduces 30-day readmission — CMS quality metric

PCSK9 inhibitor add-on if LDL >55 despite high-intensity statin + ezetimibe

Mediastinitis risk factor: diabetes, BIMA grafting, obesity — vigilance for sternal wound drainage

Board Question Stem Patterns

— "A 68-year-old man, day 3 post inferior STEMI treated with PCI, develops sudden dyspnea, BP 80/50, bilateral crackles, soft systolic murmur at apex." → Acute MR from PMR — order TTE, IABP, nitroprusside, emergent CT surgery consult; expect flail posteromedial leaflet on echo

— "Day 5 post-anterior STEMI, late presenter without reperfusion. New harsh holosystolic murmur with thrill at LLSB, JVD, hypotension." → VSR — confirm with TTE color Doppler and O₂ step-up on RHC; IABP + inotropes + surgical repair

— "Day 4 post-MI, sudden chest pain, then PEA. Echo shows large pericardial effusion with RV diastolic collapse." → Subacute FWR with tamponade — pericardiocentesis (bridge) + emergent surgical repair

— "3 weeks post inferior MI, gradual dyspnea, embolic stroke. Echo shows outpouching with narrow neck from inferior wall." → Pseudoaneurysm — urgent surgical repair regardless of symptoms

— "4 weeks post anterior MI, persistent ST elevation in V1–V4, dyskinetic apex on echo, LV thrombus." → True LV aneurysm — anticoagulate for thrombus, GDMT, surgery only for refractory symptoms

— "6 weeks post-MI, pleuritic chest pain, friction rub, diffuse ST elevation, small effusion." → Dressler — high-dose aspirin + colchicine; avoid NSAIDs/steroids

— "Inferior STEMI, hypotension, clear lungs, JVD." → RV infarction, not mechanical complication — fluids, avoid nitrates

— "Day 4 post-MI patient given ibuprofen for shoulder pain develops chest pain and PEA." → NSAID impaired healing → FWR

— "Post-MI LVEF 25% at day 5. When to implant ICD?" → Reassess at 40 days post-MI, bridge with wearable defibrillator

— "Patient discharged post-VSR repair. When should PCP see them?" → Within 7 days

Key distinction: Acute MR has a soft apical murmur with flash pulmonary edema and giant V waves; VSR has a loud LLSB murmur with thrill, biventricular failure, and O₂ step-up. Mix these up and you miss the question.

Stem 1 — PMR:

Stem 2 — VSR:

Stem 3 — FWR:

Stem 4 — Pseudoaneurysm:

Stem 5 — True aneurysm:

Stem 6 — Dressler:

Stem 7 — RV infarct mimic:

Stem 8 — Drug pitfall:

Stem 9 — Timing of ICD:

Stem 10 — Transition of care:

One-Line Recap

Mechanical complications of MI — papillary muscle rupture, ventricular septal rupture, free wall rupture, and pseudoaneurysm — present 2–7 days post-infarct with sudden hemodynamic collapse, demand immediate bedside echo and concurrent activation of IABP/MCS plus cardiothoracic surgery, and remain the highest-mortality lesions in cardiology even in the reperfusion era.

Board pearl: The single highest-yield reflex for Step 3 is: "Post-MI, new murmur, sudden shock → bedside echo + IABP + surgery consult now."

Timing rule: Suspect mechanical complication in any post-MI patient who decompensates between days 2 and 7 — the necrosis-and-macrophage window. Late presenters without reperfusion, anterior or inferior first MIs, elderly women, and those given NSAIDs/steroids are highest risk.

Diagnosis rule: Stat TTE + TEE if needed identifies the lesion; right heart catheterization with O₂ step-up ≥7% confirms VSR; pericardiocentesis with non-clotting bloody fluid confirms FWR. New murmur + shock = echo within minutes, not hours.

Management rule: IABP + inotrope (dobutamine/milrinone) + afterload reduction (nitroprusside) + emergent CT surgery consult, all activated concurrently in the first clock advance on CCS. Hold P2Y12 inhibitors pre-op when feasible; do not delay surgery for full anticoagulation washout in extremis. Transcatheter closure (Amplatzer for VSR, MitraClip for PMR) is a fallback for non-surgical candidates.

Long-term rule: Survivors need full post-MI GDMT (DAPT, high-intensity statin, β-blocker, ACEi/ARB or ARNI, MRA, SGLT2i), cardiac rehab referral before discharge, 7-day post-discharge follow-up, LVEF reassessment at 40 days for ICD candidacy, and structured depression/PTSD screening — with palliative care embedded from day one for patients who are not surgical candidates.